Journal
INFLAMMATORY BOWEL DISEASES
Volume 28, Issue 10, Pages 1614-1617Publisher
OXFORD UNIV PRESS INC
DOI: 10.1093/ibd/izac053
Keywords
Autoimmune disease; Demyelination; Anti-TNF therapy
Categories
Funding
- NIH/NIDDK [K23DK117058, R03DK129631]
- AbbVie
- Takeda
Ask authors/readers for more resources
Patients with both MS and IBD had similar rates of stricturing, fistulizing, and extensive IBD compared to IBD controls. Although MS-IBD patients were less likely to start anti-TNF therapy, their risk of surgery did not worsen during follow-up.
Lay Summary Patients with MS and IBD were as likely to have stricturing, fistulizing, and extensive IBD as IBD controls. Although MS-IBD patients were less likely to initiate anti-TNF therapy, they did not have worsened risk of progression to surgery on follow-up.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available